Klor-con m20 and Ibrance drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Klor-con m20 (potassium chloride) and Ibrance (palbociclib). Common drug interactions include fatigue among females.
The phase IV clinical study analyzes what interactions people have when they take Klor-con m20 and Ibrance. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Klor-con m20?
Klor-con m20 has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 2,411 Klor-con m20 users. Check the latest studies of Klor-con m20.
What is Ibrance?
Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.
38 people who take Klor-con m20 and Ibrance together, and have interactions are studied.
What are the common drug interactions of Klor-Con M20 and Ibrance, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Diarrhoea
- Bone pain
- Full blood count decreased
- Hyperhidrosis (abnormally increased sweating)
- Myalgia (muscle pain)
- Pain
- Asthenia (weakness)
- Back pain
- Blood glucose decreased
male:
n/a
What are the common drug interactions of Klor-Con M20 and Ibrance, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Diarrhoea
- Hepatic failure (liver failure)
- Oedema (fluid collection in tissue)
- Platelet count decreased
- Stomatitis (inflammation of mucous membrane of mouth)
40-49:
n/a
50-59:
- Anaemia (lack of blood)
- Breast cancer
- Confusional state
- Constipation
- Death
- Diarrhoea
- Disease progression
- Fatigue (feeling of tiredness)
- Haemoglobin decreased
- Nausea (feeling of having an urge to vomit)
60+:
- Fatigue (feeling of tiredness)
- White blood cell count decreased
- Full blood count decreased
- Hyperhidrosis (abnormally increased sweating)
- Myalgia (muscle pain)
- Pain
- Nausea (feeling of having an urge to vomit)
- Asthenia (weakness)
- Back pain
- Blood glucose decreased
What are the existing conditions these people have? *
- Breast Cancer Female: 18 people, 47.37%
- Breast Cancer Metastatic: 14 people, 36.84%
- Breast Cancer: 3 people, 7.89%
- High Blood Pressure: 2 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Klor-con m20 and Ibrance?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Klor-con m20 (2,411 reports)
- Ibrance (104,434 reports)
Browse all drug interactions of Klor-con m20 and Ibrance:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Klor-con m20:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ibrance:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Klor-con m20 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ibrance and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on potassium chloride and palbociclib (the active ingredients of Klor-con m20 and Ibrance, respectively), and Klor-con m20 and Ibrance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Brimonidine Tartrate vs. Timoptic-Xe, side effect and effectiveness comparison - 9 seconds ago
- Could Calcium cause Ulcerative Keratitis? - 11 seconds ago
- Could Avapro cause Emphysema? - 15 seconds ago
- Drug interactions of Risperdal and Tresiba - 20 seconds ago
- Could Lorazepam cause Tooth Loss? - 36 seconds ago
- Drug interactions of Paxlovid and Loraz - a minute ago
- Could Plavix cause Atrioventricular Block First Degree? - a minute ago
- Drug interactions of Levonorgestrel and Nystatin - a minute ago
- Could Ativan cause Blood Thyroid Stimulating Hormone Decreased? - a minute ago
- Drug interactions of Zolpidem and Cephalexin - a minute ago